Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis

Area of Science:

• Immunology
• Biomaterials Science
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a complex autoimmune disease causing joint inflammation and bone damage.
• RA pathogenesis involves immune system dysregulation, including innate and adaptive immunity disruptions.
• Current RA treatments are often limited, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the immune microenvironment's role in rheumatoid arthritis pathogenesis.
• To analyze the application of nonpharmaceutical biomaterials as therapeutic microenvironment modulators for RA.
• To explore novel biomaterial-based strategies for RA treatment.

Main Methods:

• Review of scientific literature on RA immunology and biomaterials.
• Analysis of biomaterials' mechanisms in modulating RA's immune microenvironment.
• Categorization of biomaterials based on therapeutic principles: biofactor regulation, gas adjustment, and immune cell modulation.

Main Results:

• Biomaterials can act as therapeutic microenvironment modulators, offering drug-independent RA treatment.
• Novel biomaterials target key aspects of RA pathogenesis, including signaling pathways and immune cells.
• Three primary mechanisms of biomaterial action in RA treatment are identified: biofactor/signaling regulation, endogenous gas adjustment, and immune cell modulation.

Conclusions:

• Nonpharmaceutical biomaterials represent a promising avenue for innovative rheumatoid arthritis treatment strategies.
• Modulating the immune microenvironment via biomaterials offers a new perspective beyond traditional pharmaceuticals.
• Further research into biomaterial composition, form, and therapeutic efficacy is warranted to advance RA treatment.